143 related articles for article (PubMed ID: 4383257)
1. [Clinical studies with propericiazine].
Eckmann F; Immich H; Schäpperle O; Schwarz H
Med Klin; 1966 Jan; 61(4):142-3. PubMed ID: 4383257
[No Abstract] [Full Text] [Related]
2. [Selectivity of action of propericiazine in behavior disorders].
Nardini L; Pistoni A
Riv Sper Freniatr Med Leg Alien Ment; 1967 Apr; 91(2):569-75. PubMed ID: 4384082
[No Abstract] [Full Text] [Related]
3. A controlled trial of propericiazine and chlorpromazine in "behaviour disorders".
Rajotte P; Giard N; Tétreault L
Curr Ther Res Clin Exp; 1966 Apr; 8(4):166-74. PubMed ID: 4379671
[No Abstract] [Full Text] [Related]
4. [Use of the combination of propericiazine with chlorpromazine in the psychiatric field].
Ostaptzeff G; Ostaptzeff-Lavoine M
Ann Med Psychol (Paris); 1965 Dec; 123(5):655-64. PubMed ID: 4379140
[No Abstract] [Full Text] [Related]
5. [Clinical study of a new neuroleptic drug: propericiazine (FI 6145)].
Grava C; Bressani F
G Psichiatr Neuropatol; 1966; 94(3):817-26. PubMed ID: 4381171
[No Abstract] [Full Text] [Related]
6. [A comparative study of propericiazine in the management of antisocial behavior].
Ferguson K; Ban TA; Lehmann HE; Lee H
Union Med Can; 1967 Apr; 96(4):448-9. PubMed ID: 4382825
[No Abstract] [Full Text] [Related]
7. [Effect of propericiazine (Neuleptil) on the Rorschach psychodiagnostic test in children during differential treatment].
Ronco P; Mezzena G; Priora PM
Minerva Med; 1968 Jul; 59(53):3003-7. PubMed ID: 4386141
[No Abstract] [Full Text] [Related]
8. [Effect of propericiazine on behavior disorders of children and adolescents].
Duche DJ
Laval Med; 1970 Jun; 41(6):784-8. PubMed ID: 4396436
[No Abstract] [Full Text] [Related]
9. [Sociopsychological aspects of the introduction of a new psychotropic drug in a closed hospital service. Methodological reflections concerning 52 patients treated with propericiazine].
Garneret N; Boissenin JM; Muyard JP
Encephale; 1965; 54(3):265-83. PubMed ID: 4378570
[No Abstract] [Full Text] [Related]
10. [Neuleptil (propericiazine)--an correcting drug in behavior disorders. Preliminary report].
Alapin B; Stańczak T
Neurol Neurochir Psychiatr Pol; 1966 Oct; 16(10):1167-71. PubMed ID: 4384653
[No Abstract] [Full Text] [Related]
11. Pericyazine in clinical practice.
Jenner FA
Laval Med; 1970 Jun; 41(6):796-804. PubMed ID: 5509701
[No Abstract] [Full Text] [Related]
12. Clinical experience with piperacetazine in hospitalized mental patients. A four year study.
Ralston JD; Abreu BE
J Indiana State Med Assoc; 1970 Nov; 63(11):1291-6. PubMed ID: 5495472
[No Abstract] [Full Text] [Related]
13. [Clinical study of oxaflumazine; its place among the neuroleptics].
Deniker P; Ginestet D; Peron-Magnan P; Colonna L; Loo H
Therapie; 1971; 26(1):227-33. PubMed ID: 5554766
[No Abstract] [Full Text] [Related]
14. [Progress in therapy. A remedy for character disorders].
Rass Int Clin Ter; 1966 Jun; 46(11):615. PubMed ID: 4383987
[No Abstract] [Full Text] [Related]
15. Propericiazine in psychiatric emergencies. A controlled comparative study.
Ananth JV; Salib M; Ban TA; Lehmann HE
Can Psychiatr Assoc J; 1972 Apr; 17(2):143-5. PubMed ID: 4402542
[No Abstract] [Full Text] [Related]
16. A clinical trial with mesoridazine (another phenodiazine derivative).
Rudy L; Marozas RJ; Sykes D; Smith JA
Dis Nerv Syst; 1968 Jun; 29(6):412-3. PubMed ID: 4877749
[No Abstract] [Full Text] [Related]
17. [Electroencephalographic studies of a triflumethyl-phenothiazine derivative].
Itil TM
Arzneimittelforschung; 1965 Jul; 15(7):817-9. PubMed ID: 5898686
[No Abstract] [Full Text] [Related]
18. [Clinical experiences with the neuroleptic butyryl-perazine (Wu 2791-AWD). Contribution to the syndromatic concept of endogenous psychoses].
Kühne GE; Rennert H
Z Arztl Fortbild (Jena); 1965 Feb; 59(3):140-6. PubMed ID: 5885796
[No Abstract] [Full Text] [Related]
19. [Clinical expressions of aggressive behavior and their treatment].
Montanini R; Mastruzzo A; Giovannucci M
G Psichiatr Neuropatol; 1968; 96(3):567-76. PubMed ID: 4389866
[No Abstract] [Full Text] [Related]
20. [Clinical evaluation of the TPN 12 (Sandoz) preparation in the treatment of mental disorders].
Bukowczyk A; Korta B; Michalska M; Spisla B; Trzeciakowa O; Bryś J
Psychiatr Pol; 1971; 5(5):571-5. PubMed ID: 4400423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
